Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319965071> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4319965071 endingPage "89" @default.
- W4319965071 startingPage "89" @default.
- W4319965071 abstract "Hypochlorous acid (HOCl) is a potent anti-bacterial agent which could reduce periprosthetic joint infection. Early infection complications in joint replacements are often considered to be due to local contamination at the time of surgery and result in a significant socioeconomic cost. Current theatre cleaning procedures produce “clean” operating theatres which still contain bacteria (colony forming units, CFU). Reducing this bacterial load may reduce local contamination at the time of surgery. HOCl is produced naturally in the human neutrophil and has been implicated as the primary agent involved in bacterial killing during this process. In vitro research confirms its efficacy against essentially all clinically relevant bacteria. The recent advent of commercial production of HOCl, delivered as a fog, has resulted in extensive use in the food industry. Reported lack of corrosion and high anti-bacterial potency are seen as two key factors for the use of HOCl in the orthopaedic environment. Prior work by the authors comparing human cell toxicity of HOCl, chlorhexidine and iodine solutions shows favourable results. This study evaluates use of neutral HOCl applied as a dry room fog to decrease bacteria in the operating theatre environment. Using an animal operating theatre as the test site, bacterial swabs were taken from ten 100cm 2 sample areas before standard cleaning with detergent, after standard cleaning, and again after 60 minutes exposure to HOCl fog. After standard cleaning, 6 of 10 sample sites recorded significant bacterial growth (>10 CFU/100cm 2 ). After exposure to HOCl fog, growth in all 10 sites was below detection limits (<10 CFU/100cm 2 ). This was repeated with specific exposure to Staphylococcus aureus and Escherichia coli. We can conclude that HOCl is effective when used as a fogging agent to reduce bacterial loading within an operating theatre environment and as such has significant potential to reduce intraoperative contamination and periprosthetic infection." @default.
- W4319965071 created "2023-02-11" @default.
- W4319965071 creator A5005842855 @default.
- W4319965071 creator A5015866577 @default.
- W4319965071 creator A5069821826 @default.
- W4319965071 creator A5088892854 @default.
- W4319965071 creator A5089466968 @default.
- W4319965071 date "2023-02-01" @default.
- W4319965071 modified "2023-10-06" @default.
- W4319965071 title "NEUTRAL HYPOCHLOROUS ACID SOLUTION AS AN ORTHOPAEDIC STERILIZATION AGENT" @default.
- W4319965071 doi "https://doi.org/10.1302/1358-992x.2023.2.089" @default.
- W4319965071 hasPublicationYear "2023" @default.
- W4319965071 type Work @default.
- W4319965071 citedByCount "0" @default.
- W4319965071 crossrefType "journal-article" @default.
- W4319965071 hasAuthorship W4319965071A5005842855 @default.
- W4319965071 hasAuthorship W4319965071A5015866577 @default.
- W4319965071 hasAuthorship W4319965071A5069821826 @default.
- W4319965071 hasAuthorship W4319965071A5088892854 @default.
- W4319965071 hasAuthorship W4319965071A5089466968 @default.
- W4319965071 hasConcept C112570922 @default.
- W4319965071 hasConcept C148761745 @default.
- W4319965071 hasConcept C162324750 @default.
- W4319965071 hasConcept C17741926 @default.
- W4319965071 hasConcept C185592680 @default.
- W4319965071 hasConcept C18903297 @default.
- W4319965071 hasConcept C199343813 @default.
- W4319965071 hasConcept C2777084678 @default.
- W4319965071 hasConcept C2780908991 @default.
- W4319965071 hasConcept C2983132609 @default.
- W4319965071 hasConcept C523546767 @default.
- W4319965071 hasConcept C536366893 @default.
- W4319965071 hasConcept C54355233 @default.
- W4319965071 hasConcept C55493867 @default.
- W4319965071 hasConcept C556758197 @default.
- W4319965071 hasConcept C71924100 @default.
- W4319965071 hasConcept C86803240 @default.
- W4319965071 hasConcept C89423630 @default.
- W4319965071 hasConceptScore W4319965071C112570922 @default.
- W4319965071 hasConceptScore W4319965071C148761745 @default.
- W4319965071 hasConceptScore W4319965071C162324750 @default.
- W4319965071 hasConceptScore W4319965071C17741926 @default.
- W4319965071 hasConceptScore W4319965071C185592680 @default.
- W4319965071 hasConceptScore W4319965071C18903297 @default.
- W4319965071 hasConceptScore W4319965071C199343813 @default.
- W4319965071 hasConceptScore W4319965071C2777084678 @default.
- W4319965071 hasConceptScore W4319965071C2780908991 @default.
- W4319965071 hasConceptScore W4319965071C2983132609 @default.
- W4319965071 hasConceptScore W4319965071C523546767 @default.
- W4319965071 hasConceptScore W4319965071C536366893 @default.
- W4319965071 hasConceptScore W4319965071C54355233 @default.
- W4319965071 hasConceptScore W4319965071C55493867 @default.
- W4319965071 hasConceptScore W4319965071C556758197 @default.
- W4319965071 hasConceptScore W4319965071C71924100 @default.
- W4319965071 hasConceptScore W4319965071C86803240 @default.
- W4319965071 hasConceptScore W4319965071C89423630 @default.
- W4319965071 hasIssue "SUPP_2" @default.
- W4319965071 hasLocation W43199650711 @default.
- W4319965071 hasOpenAccess W4319965071 @default.
- W4319965071 hasPrimaryLocation W43199650711 @default.
- W4319965071 hasRelatedWork W1604999514 @default.
- W4319965071 hasRelatedWork W1987249708 @default.
- W4319965071 hasRelatedWork W2003546559 @default.
- W4319965071 hasRelatedWork W2086475541 @default.
- W4319965071 hasRelatedWork W2153943102 @default.
- W4319965071 hasRelatedWork W2182932152 @default.
- W4319965071 hasRelatedWork W2358043360 @default.
- W4319965071 hasRelatedWork W2387290342 @default.
- W4319965071 hasRelatedWork W3178472217 @default.
- W4319965071 hasRelatedWork W6168563 @default.
- W4319965071 hasVolume "105-B" @default.
- W4319965071 isParatext "false" @default.
- W4319965071 isRetracted "false" @default.
- W4319965071 workType "article" @default.